在接受新辅助免疫化疗后,局部晚期胃癌的凝血标志物的预后值
Arunkumar Krishnan1,2, Diptasree Mukherjee3
1Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27103, United States.
World journal of gastrointestinal oncology
|August 21, 2025
概括
在接受新辅助免疫化疗 (NICT) 的局部晚期胃癌 (LAGC) 患者中,高凝血是有前景的预后生物标志物. 需要进一步的研究来验证这些发现的大型多中心研究.
科学领域:
- 癌症学
- 血液学
- 生物标志物发现
背景情况:
- 胃癌仍然是一个重大的全球健康挑战.
- 非侵入性生物标志物对于改善癌症诊断和治疗至关重要.
- 血凝过高正在成为癌症的潜在预后指标.
研究的目的:
- 在局部晚期胃癌 (LAGC) 患者中评估高凝血的预后值.
- 确定当前研究的局限性,并提出未来的方向.
- 探索凝血标记与其他临床数据的整合,以进行风险分层.
主要方法:
- 对高凝血和LAGC现有研究的审查.
- 局限性分析包括回顾性设计,单中心聚焦和小样本大小.
- 讨论前性多中心试验和机器学习整合的必要性.
主要成果:
- 在新辅助免疫化疗 (NICT) 后的LAGC患者中,高凝血显示出潜在的预后生物标志物.
- 现有研究受到回顾性设计,单中心数据和小样本大小的限制.
- 术前并发症和全身炎症需要进一步调查.
结论:
- 未来的多中心试验对于验证高凝血作为预后生物标志物至关重要.
- 机器学习算法可以通过将凝血标记与临床变量集成来增强风险分层.
- 包括生活方式干预和高级成像在内的多学科方法对于改善GC患者的结果至关重要.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


